Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
Year: 2023
Type: article
Authors: Junjie Zhu, Saifei Lei, Jie Lu, Yixuan Hao, Qi Qian, Aaron S. Devanathan, Zhiwei Feng, Xiang-Qun Xie, Peter Wipf, Xiaochao Ma
Institution: University of Pittsburgh
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: University of Pittsburgh, University of Pittsburgh School of Pharmacy, National Institute on Aging, National Institute on Drug Abuse, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Toward a deeper understanding of allostery and allotargeting by computational approaches, Pharmacoenhancers for antiretroviral therapy: safety and future development, NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR), SmartAD for Intelligent Alzheimer’s Disease(AD) Personalized Combination Therapy, The ABCG2 transporter in protoporphyrin IX disposition: from toxicity to therapy
OpenAlex ID: W4384832135